Date published: 2026-2-23

1-800-457-3801

SCBT Portrait Logo
Seach Input

dCtBP Inhibitors

dCtBP, or C-terminal binding protein, is a well-studied protein known for its role as a transcriptional corepressor. In various organisms, dCtBP forms complexes with specific transcription factors and contributes to the suppression of gene expression. This protein functions by interacting with the C-terminal PDZ-binding motif of target proteins, assisting in the regulation of gene networks crucial for multiple biological processes. dCtBP's involvement in such regulatory mechanisms underlines its importance in cellular differentiation, growth, and development. In some contexts, dCtBP has also been associated with the modulation of apoptotic pathways, where it can influence cell survival. Given its pivotal role in these cellular processes, dysregulation of dCtBP function or expression can be associated with various pathological conditions. dCtBP Inhibitors represent a class of chemical compounds specifically designed to target and hinder the functions of the dCtBP protein. By inhibiting dCtBP, these compounds can modulate the transcriptional regulatory networks in which dCtBP plays a role. The precise mechanisms of action of these inhibitors can vary, but common strategies include preventing dCtBP from forming complexes with its partner transcription factors or blocking its interaction with target genes, thereby altering the transcriptional outcome. Given dCtBP's central role in cellular regulation, understanding the intricacies of its inhibition provides valuable insights into the broader landscape of gene expression control. Investigating these inhibitors and their interactions with dCtBP not only expands our understanding of transcriptional regulation but also offers potential tools for research into the modulation of gene networks and the intricate balance between gene activation and repression.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

NSC697923

343351-67-7sc-391107
sc-391107A
1 mg
5 mg
$15.00
$52.00
3
(1)

NSC 95397 is known to inhibit CtBP by targeting its dehydrogenase activity, potentially affecting the stability and function of dCtBP.

Gossypol

303-45-7sc-200501
sc-200501A
25 mg
100 mg
$116.00
$230.00
12
(1)

Gossypol, a natural polyphenolic compound, has been reported to inhibit CtBP. This might indirectly influence dCtBP expression or activity.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

While primarily a kinase inhibitor, sorafenib affects various pathways and might indirectly influence dCtBP expression or activity.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This DNA methyltransferase inhibitor can alter gene expression profiles, possibly influencing dCtBP expression indirectly.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

As an HDAC inhibitor, vorinostat can influence transcription and might have indirect effects on dCtBP expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

A DNA hypomethylating agent that can affect gene expression, possibly influencing dCtBP expression indirectly.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

As a DNA methyltransferase inhibitor, RG108 can alter gene expression, possibly having indirect effects on dCtBP expression.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Being an HDAC inhibitor, valproic acid can influence transcription, potentially having indirect effects on dCtBP expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Another HDAC inhibitor, trichostatin A, can affect gene expression profiles, which might influence dCtBP expression indirectly.

Zebularine

3690-10-6sc-203315
sc-203315A
sc-203315B
10 mg
25 mg
100 mg
$129.00
$284.00
$1004.00
3
(1)

A DNA methyltransferase inhibitor that might indirectly influence dCtBP expression by altering the gene expression landscape.